Found: 28
Select item for more details and to access through your institution.
Impact of COVID-19 on pregnancy and fetal outcomes in women with multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 6, p. 707, doi. 10.1177/13524585241232266
- By:
- Publication type:
- Article
Sars-CoV2 infection in pregnant women with multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 9, p. 1090, doi. 10.1177/13524585231176174
- By:
- Publication type:
- Article
Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 7, p. 856, doi. 10.1177/13524585231167515
- By:
- Publication type:
- Article
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 13, p. 2106, doi. 10.1177/13524585221102918
- By:
- Publication type:
- Article
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 7, p. 1034, doi. 10.1177/13524585211035318
- By:
- Publication type:
- Article
Switching to ocrelizumab in RRMS patients at risk of PML previously treated with extended interval dosing of natalizumab.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 5, p. 790, doi. 10.1177/1352458520946017
- By:
- Publication type:
- Article
Assessing long-term prognosis improvement as a consequence of treatment pattern changes in MS.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 13, p. 1257, doi. 10.1177/1352458516687402
- By:
- Publication type:
- Article
Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis.
- Published in:
- Annals of Neurology, 2021, v. 89, n. 4, p. 780, doi. 10.1002/ana.26028
- By:
- Publication type:
- Article
DMTs and Covid‐19 severity in MS: a pooled analysis from Italy and France.
- Published in:
- Annals of Clinical & Translational Neurology, 2021, v. 8, n. 8, p. 1738, doi. 10.1002/acn3.51408
- By:
- Publication type:
- Article
Intravenous or subcutaneous natalizumab in patients with relapsing–remitting multiple sclerosis: investigation on efficiency and savings—the EASIER study.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 1, p. 340, doi. 10.1007/s00415-023-11955-0
- By:
- Publication type:
- Article
Patients with multiple sclerosis: a burden and cost of illness study.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 9, p. 5127, doi. 10.1007/s00415-022-11169-w
- By:
- Publication type:
- Article
Correction to: Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 6, p. 3301, doi. 10.1007/s00415-022-11009-x
- By:
- Publication type:
- Article
Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis.
- Published in:
- Journal of Neurology, 2017, v. 264, n. 2, p. 284, doi. 10.1007/s00415-016-8343-5
- By:
- Publication type:
- Article
Lung involvement correlates with disability in MS patients with COVID-19 pneumonia.
- Published in:
- Neurological Sciences, 2022, v. 43, n. 12, p. 6657, doi. 10.1007/s10072-022-06333-z
- By:
- Publication type:
- Article
Correction to: Pegylated interferon beta-1a (Plegridy) Italian real-world experience: a Delphi analysis of injection-site reaction and flu-like symptom management.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Pegylated interferon beta-1a (Plegridy) Italian real-world experience: a Delphi analysis of injection-site reaction and flu-like symptom management.
- Published in:
- Neurological Sciences, 2021, v. 42, n. 4, p. 1515, doi. 10.1007/s10072-020-04969-3
- By:
- Publication type:
- Article
Bilateral visual loss recovering after tadalafil withdrawal.
- Published in:
- 2016
- By:
- Publication type:
- case study
Early detection and favourable outcome of natalizumab-related progressive multifocal leukoencephalopathy (PML) in two multiple sclerosis patients.
- Published in:
- 2015
- By:
- Publication type:
- Letter
A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy.
- Published in:
- Neurological Sciences, 2013, v. 34, n. 2, p. 197, doi. 10.1007/s10072-012-0981-5
- By:
- Publication type:
- Article
MxA mRNA Quantification and Disability Progression in Interferon Beta-Treated Multiple Sclerosis Patients.
- Published in:
- PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0094794
- By:
- Publication type:
- Article
Sexual Dysfunction in People with Multiple Sclerosis: The Role of Disease Severity, Illness Perception, and Depression.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 6, p. 2215, doi. 10.3390/jcm12062215
- By:
- Publication type:
- Article
Age as a risk factor for early onset of natalizumab-related progressive multifocal leukoencephalopathy.
- Published in:
- Journal of NeuroVirology, 2017, v. 23, n. 5, p. 742, doi. 10.1007/s13365-017-0561-9
- By:
- Publication type:
- Article
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop).
- Published in:
- European Journal of Neurology, 2024, v. 31, n. 6, p. 1, doi. 10.1111/ene.16250
- By:
- Publication type:
- Article
Signs and symptoms of COVID‐19 in patients with multiple sclerosis.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 12, p. 3728, doi. 10.1111/ene.15554
- By:
- Publication type:
- Article
The effect of air pollution on COVID‐19 severity in a sample of patients with multiple sclerosis.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 2, p. 535, doi. 10.1111/ene.15167
- By:
- Publication type:
- Article
A real‐world study of alemtuzumab in a cohort of Italian patients.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 1, p. 257, doi. 10.1111/ene.15121
- By:
- Publication type:
- Article
Less Frequent and Less Severe Flu-Like Syndrome in Interferon Beta-1a Treated Multiple Sclerosis Patients with at Least One Allele Bearing the G>C Polymorphism at Position -174 of the IL-6 Promoter Gene.
- Published in:
- PLoS ONE, 2015, v. 10, n. 8, p. 1, doi. 10.1371/journal.pone.0135441
- By:
- Publication type:
- Article